Zynex, Inc (ZYXIQ)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Zynex, Inc (ZYXIQ) is down 56.4% since the beginning of the year. At $0 per share, ZYXIQ is trading 98.0% below its 52-week high of $3. Investors who bought $1,000 worth of ZYXIQ shares 5 years ago would now be looking at an investment worth $4.

Zynex, Inc (ZYXIQ) has returned -56.35% so far this year and -97.28% over the past 12 months. Over the last ten years, ZYXIQ has returned -14.71% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.

Based on dividend-adjusted daily data since Jul 23, 2012, ZYXIQ's average daily return is +0.19%, while the average monthly return is +1.76%. At this rate, an investment would double in approximately 3.3 years.

Historically, 45% of months were positive and 55% were negative. The best month was Dec 2015 with a return of +126.5%, while the worst month was Dec 2025 at -90.0%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 7 months.

On a daily basis, ZYXIQ closed higher 39% of trading days. The best single day was Nov 26, 2025 with a return of +115.6%, while the worst single day was Mar 12, 2025 at -51.3%.

Zynex, Inc has an annualized alpha of 44.07%, beta of 0.82, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since July 24, 2012.

• This stock participated in 185.26% of S&P 500 Index downside but only 50.62% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ZYXIQ ranks 13 for risk / return — in the bottom 13% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Zynex, Inc (ZYXIQ) and compare them to S&P 500 Index.

Zynex, Inc provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.

The table displays the monthly dividend distributions for Zynex, Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Zynex, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Zynex, Inc was 99.88%, occurring on Feb 9, 2026. The portfolio has not yet recovered.

The current Zynex, Inc drawdown is 99.79%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Zynex, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Zynex, Inc is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.